Microstructured hydrogel scaffolds containing differential density interfaces promote rapid cellular invasion and...

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Current clinical biomaterials have limited applications due to insufficient vascularization, especially in complex wounds.
• Existing dermal replacement products may not integrate well with the body, hindering optimal healing.
• Neovascularization is crucial for the successful integration of engineered tissues into wound beds.

Purpose of the Study:

• To design and evaluate a novel hydrogel scaffold with a unique microstructure to promote cellular invasion and neovascularization.
• To investigate the potential of this scaffold as a next-generation dermal replacement product.
• To compare the performance of the novel scaffold against existing clinical standards.

Main Methods:

• Fabrication of microsphere scaffolds (MSS) using type 1 collagen microspheres embedded in a collagen bulk.
• Mechanical characterization, in vitro, and in vivo invasion assays were performed.
• Cellular invasion depth, cell counts, and neovasculature formation (CD31+ structures) were analyzed.

Main Results:

• MSS demonstrated significantly greater cellular invasion depth and cell counts in vitro compared to controls (Integra®, monophase collagen).
• In vivo studies showed significantly more cellular invasion throughout the MSS scaffold at 14 days compared to Integra®.
• Evidence of neovasculature formation, including CD31+ structures and erythrocytes, was observed within MSS by 7-14 days.

Conclusions:

• The developed hydrogel scaffold effectively induces cellular migration and neovascularization through its differential collagen density microstructure.
• MSS shows superior performance compared to the current clinical standard, Integra®.
• This innovative scaffold holds significant potential for clinical translation as an advanced dermal replacement product.